Emergent Biosolutions (EBS)

$6.77 +0.25 (3.83%)
Market Cap 353.89M
Revenue (ttm) 1.04B
Net Income (ttm) -190.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 9.15
Profit Margin -18.26%
Debt to Equity Ratio 1.20
Volume 1,059,800
Avg Vol 1,160,080
Day's Range N/A - N/A
Shares Out 54.28M
Stochastic %K 78%
Beta 2.10
Analysts Sell
Price Target $13.50

Company Profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States. The company offers NARCAN Nasal Spray for the emergency treatment of known or suspected opioid overdose; Vaxchora vaccine for the prevention of cholera; Vivotif vaccine for oral administration for the prevention of typhoid fever; Anthrasil for the treatment of inhalational anthrax; BioThrax, an anthrax va...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240 631 3200
Address:
300 Professional Drive, Gaithersburg, United States
billywilliamz
billywilliamz Jun. 25 at 1:43 PM
$EBS and we sick again. Sorry guys nothing to do here except wait
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 25 at 1:28 PM
$EBS Alright lads! If we breach and hold $6.95 (200D EMA), male astrologers will flocking here.
1 · Reply
Rolltide2020
Rolltide2020 Jun. 25 at 1:05 PM
$EBS NATO agreeing to 5% defense spending target with 3.5% being pure defense.
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 25 at 12:51 PM
$EBS Not to mention the 'reorganization' which is also called "SHIFT AND SHAFT"
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 25 at 12:50 PM
$EBS RFK Jr testified HHS is 'taking inventory' at SNS right now. This may delay things. Plus, Democritters accused his department of filtering spending via 'political appointees' using a "DEFEND THE SPEND" mantra, which should be interpreted as "TRY TO SHAFT CONGRESS/BUDGET"
0 · Reply
JTMinor1
JTMinor1 Jun. 25 at 12:27 PM
$EBS looking like shorts have 2 sessions left to cover.
0 · Reply
billywilliamz
billywilliamz Jun. 25 at 12:13 PM
$EBS sold roughly 4,000 shares yesterday we shoukd skyrocket today. LFG
1 · Reply
ComradeKomisar
ComradeKomisar Jun. 25 at 12:12 PM
$EBS
0 · Reply
billywilliamz
billywilliamz Jun. 25 at 12:04 PM
$EBS we went to 0.00 ? Shit
1 · Reply
Rolltide2020
Rolltide2020 Jun. 25 at 11:13 AM
$EBS Would be nice to get some more big news in the next couple days to drive pricing up as high as possible before funds have to buy Friday. Could get squeezy.
1 · Reply
Latest News on EBS
Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Jun 23, 2025, 8:05 AM EDT - 2 days ago

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Jun 20, 2025, 2:25 PM EDT - 4 days ago

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Emergent BioSolutions Announces Addition to Russell 3000® Index

Jun 20, 2025, 8:13 AM EDT - 5 days ago

Emergent BioSolutions Announces Addition to Russell 3000® Index

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

Jun 5, 2025, 7:00 AM EDT - 20 days ago

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

Emergent BioSolutions to Participate in Upcoming Investor Conferences

May 14, 2025, 7:32 AM EDT - 6 weeks ago

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

May 7, 2025, 10:01 PM EDT - 6 weeks ago

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

Emergent BioSolutions Reports First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 6 weeks ago

Emergent BioSolutions Reports First Quarter 2025 Financial Results

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

May 1, 2025, 5:07 PM EDT - 7 weeks ago

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Apr 22, 2025, 8:00 AM EDT - 2 months ago

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Emergent BioSolutions Announces Stock Repurchase Program

Mar 31, 2025, 8:00 AM EDT - 3 months ago

Emergent BioSolutions Announces Stock Repurchase Program

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Mar 20, 2025, 4:30 PM EDT - 3 months ago

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Mar 20, 2025, 8:06 AM EDT - 3 months ago

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 19, 2025, 4:30 PM EDT - 3 months ago

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

Mar 18, 2025, 8:00 AM EDT - 3 months ago

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Mar 13, 2025, 8:29 AM EDT - 3 months ago

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Mar 12, 2025, 8:00 AM EDT - 3 months ago

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Mar 10, 2025, 9:14 AM EDT - 3 months ago

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:58 PM EST - 4 months ago

Emergent BioSolutions Inc. (EBS) Q4 2024 Earnings Call Transcript

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 3, 2025, 4:23 PM EST - 4 months ago

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Feb 18, 2025, 8:55 AM EST - 4 months ago

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Feb 7, 2025, 8:06 AM EST - 4 months ago

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Jan 16, 2025, 8:00 AM EST - 5 months ago

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

Emergent BioSolutions: Stock Is A Likely Winner In 2025

Jan 14, 2025, 7:53 AM EST - 5 months ago

Emergent BioSolutions: Stock Is A Likely Winner In 2025

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Jan 14, 2025, 7:30 AM EST - 5 months ago

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Jan 13, 2025, 9:27 AM EST - 5 months ago

Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Jan 8, 2025, 7:45 AM EST - 6 months ago

Emergent BioSolutions to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

Jan 8, 2025, 7:30 AM EST - 6 months ago

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

Dec 2, 2024, 5:49 PM EST - 7 months ago

SIGA Technologies Vs Emergent BioSolutions: Product Portfolio And Future Outlook

SIGA

Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic

Nov 8, 2024, 9:25 AM EST - 8 months ago

Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024

Nov 7, 2024, 2:06 PM EST - 8 months ago

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024

Emergent BioSolutions Inc. (EBS) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 10:08 PM EST - 8 months ago

Emergent BioSolutions Inc. (EBS) Q3 2024 Earnings Call Transcript

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

Nov 6, 2024, 4:49 PM EST - 8 months ago

Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024

Oct 23, 2024, 7:30 AM EDT - 8 months ago

Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

Oct 8, 2024, 5:32 PM EDT - 9 months ago

Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic

Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario

Oct 4, 2024, 9:48 AM EDT - 9 months ago

Emergent BioSolutions: Strategic Shifts Present A Turnaround Scenario

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

Sep 26, 2024, 8:05 AM EDT - 9 months ago

Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts

Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines

Sep 25, 2024, 10:33 AM EDT - 9 months ago

Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

Sep 25, 2024, 7:07 AM EDT - 9 months ago

Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

Sep 12, 2024, 8:30 AM EDT - 10 months ago

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile

Sep 3, 2024, 7:08 AM EDT - 10 months ago

Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile

Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho's Jared Holz

Aug 30, 2024, 6:45 PM EDT - 10 months ago

Upside for Emergent Bio if they can get Mpox vaccine rollout right, says Mizuho's Jared Holz

Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

Aug 30, 2024, 8:16 AM EDT - 10 months ago

Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection

Aug 30, 2024, 7:43 AM EDT - 10 months ago

Mpox Vaccine: Emergent BioSolutions' Smallpox Vaccine Gets FDA Nod For Expanded Use For Individuals At High Risk Of Mpox Infection

Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine

Aug 30, 2024, 7:15 AM EDT - 10 months ago

Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine

US FDA approves use of Emergent's smallpox vaccine for people at high risk of mpox

Aug 29, 2024, 7:21 PM EDT - 10 months ago

US FDA approves use of Emergent's smallpox vaccine for people at high risk of mpox

Emergent BioSolutions' ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions

Aug 29, 2024, 6:53 PM EDT - 10 months ago

Emergent BioSolutions' ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions

Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

Aug 20, 2024, 11:30 AM EDT - 11 months ago

Emergent BioSolutions Finalizes Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals

Emergent to donate 50,000 vaccine doses to address mpox outbreak in Africa

Aug 19, 2024, 5:30 PM EDT - 11 months ago

Emergent to donate 50,000 vaccine doses to address mpox outbreak in Africa

Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

Aug 19, 2024, 5:10 PM EDT - 11 months ago

Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa

Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval

Aug 18, 2024, 9:00 AM EDT - 11 months ago

Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval

billywilliamz
billywilliamz Jun. 25 at 1:43 PM
$EBS and we sick again. Sorry guys nothing to do here except wait
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 25 at 1:28 PM
$EBS Alright lads! If we breach and hold $6.95 (200D EMA), male astrologers will flocking here.
1 · Reply
Rolltide2020
Rolltide2020 Jun. 25 at 1:05 PM
$EBS NATO agreeing to 5% defense spending target with 3.5% being pure defense.
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 25 at 12:51 PM
$EBS Not to mention the 'reorganization' which is also called "SHIFT AND SHAFT"
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 25 at 12:50 PM
$EBS RFK Jr testified HHS is 'taking inventory' at SNS right now. This may delay things. Plus, Democritters accused his department of filtering spending via 'political appointees' using a "DEFEND THE SPEND" mantra, which should be interpreted as "TRY TO SHAFT CONGRESS/BUDGET"
0 · Reply
JTMinor1
JTMinor1 Jun. 25 at 12:27 PM
$EBS looking like shorts have 2 sessions left to cover.
0 · Reply
billywilliamz
billywilliamz Jun. 25 at 12:13 PM
$EBS sold roughly 4,000 shares yesterday we shoukd skyrocket today. LFG
1 · Reply
ComradeKomisar
ComradeKomisar Jun. 25 at 12:12 PM
$EBS
0 · Reply
billywilliamz
billywilliamz Jun. 25 at 12:04 PM
$EBS we went to 0.00 ? Shit
1 · Reply
Rolltide2020
Rolltide2020 Jun. 25 at 11:13 AM
$EBS Would be nice to get some more big news in the next couple days to drive pricing up as high as possible before funds have to buy Friday. Could get squeezy.
1 · Reply
Rolltide2020
Rolltide2020 Jun. 25 at 9:00 AM
$EBS
1 · Reply
NRG8
NRG8 Jun. 25 at 6:16 AM
$EBS $EBS share price... 25 June 2024 $6.89 29 July 2024 $14.77 Increase in sp +114% With inclusion in Russell 3000 at the end of this week, index fund buying and further MCM orders (including ACAM 2000), it is highly likely history will repeat itself and the $EBS share price will be a lot higher by the end of July... .
0 · Reply
NRG8
NRG8 Jun. 25 at 6:06 AM
$EBS $EBS just filed 8-K with SEC about the $62.4m contract. Combination of inclusion in Russell 3000, index fund buying, and additional MCM orders (especially for ACAM2000), could trigger share price re-rating of 100%... .
1 · Reply
WinstonSmith33
WinstonSmith33 Jun. 25 at 2:56 AM
$EBS a year ago. 100M$ option contract of ACAM2000 has been exercised. Literally 3 days left, if this is to happen again. https://www.usaspending.gov/award/CONT_AWD_75A50119C00071_7505_-NONE-_-NONE-
1 · Reply
ComradeKomisar
ComradeKomisar Jun. 25 at 12:19 AM
$EBS I sense the same.
3 · Reply
zredpill
zredpill Jun. 24 at 11:32 PM
$EBS we aren't going to be in the $7 range for long... maybe just a few days, if pattern persists.
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 24 at 9:41 PM
$EBS RFK Jr. testified about the budget in the House today. He was savaged by Democritters. He was asked whether he supported the SNS budget of $750M. He does, but he is reviewing the inventory, because the SNS did not "perform" during the Covid. The New York times claims that EBS sucked that budget dry.
1 · Reply
zredpill
zredpill Jun. 24 at 9:33 PM
$EBS what’s AH volume?
1 · Reply
IntelligunInvestings
IntelligunInvestings Jun. 24 at 8:26 PM
$EBS pretty damn good day all things considered
1 · Reply
KnuckleSandwich
KnuckleSandwich Jun. 24 at 8:16 PM
$EBS closed 6.77...one the way to 7.77...we can do this!
0 · Reply
ComradeKomisar
ComradeKomisar Jun. 24 at 8:14 PM
$EBS alright! Yesterday, we only got our toes in the Good Box. Today, we're fully in, and on our way to $8.
2 · Reply
zredpill
zredpill Jun. 24 at 8:05 PM
$EBS nice looking candle . BOoooooooLLLs held in!
0 · Reply